Effect of Ketoconazole on the Pharmacokinetics of Refametinib
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if there is a difference between the way your body
absorbs and distributes BAY86-9766 when given alone or in combination with ketoconazole, a
drug which may affect how much BAY86-9766 is absorbed, distributed or eliminated from the
body